Skip to main content
NewslettersWatchlist

Stevanato Group S.P.A.(STVN-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low19.81
Day High20.60
Open:20.37
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Business Wire
Stevanato Group Reports First Quarter 2023 Financial Results
Business Wire
Stevanato Group to Present at BofA Securities Healthcare Conference
Business Wire
Stevanato Group to Report First Quarter 2023 Financial Results on May 4, 2023
Business Wire
Stevanato Group Collaborates with Thermo Fisher Scientific to Bring its Innovative On-Body Delivery System Platform to Market
Business Wire
Stevanato Group Collaborates with Recipharm to Develop and Manufacture Pre-fillable Syringes for Use in a New Soft Mist Inhaler for the Inhalation of Sensitive Biological Products
Business Wire
Stevanato Group to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
Business Wire
Stevanato Group Secures €130 Million ESG-Linked Financing From BNL BNP Paribas and Cassa Depositi e Prestiti to Support Sustainable Global Growth
Business Wire
Stevanato Group Reports Fourth Quarter and Fiscal Year 2022 Financial Results
Business Wire
Stevanato Group to Report Fourth Quarter and Fiscal Year 2022 Financial Results on March 2, 2023
Business Wire
Stevanato Group Collaborates with Transcoject to Provide Pre-Fillable Syringe Polymer Options for Pharma
Business Wire
Stevanato Group to Present at Upcoming Investor Conference
Business Wire
Stevanato Group Reports Third Quarter 2022 Financial Results
Business Wire
Stevanato Group and Gerresheimer AG Present EZ-fill Smart™, a New and Innovative Ready-To-Use Vial Platform
Business Wire
Stevanato Group and DWK Life Sciences Sign Non-Exclusive Distribution Agreement for EZ-fill® Platform Products
Business Wire
Stevanato Group to Report Third Quarter 2022 Financial Results on November 8, 2022
PR Newswire
Bexson Biomedical and Stevanato Group Awarded PDA Drug Delivery Innovation Award
Business Wire
Stevanato Group to Present at Upcoming Investor Conference
PR Newswire
Gerresheimer AG and Stevanato Group announce Collaboration on the Development of an innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
Business Wire
Stevanato Group and Gerresheimer AG Announce Collaboration on the Development of an Innovative Ready-To-Use Vial Platform for the Pharmaceutical Industry
Motley Fool
Stevanato Group S.p.A. (STVN) Q2 2022 Earnings Call Transcript
Business Wire
Stevanato Group Reports Second Quarter 2022 Financial Results
Business Wire
Stevanato Group to Report Second Quarter 2022 Financial Results on August 4, 2022
Business Wire
Stevanato Group Releases Sustainability Report 2021, Highlighting the Environmental, Social and Governance (ESG) Performance of the Group
Business Wire
Stevanato Group Announces Voting Results from its Annual General Meeting
Business Wire
Stevanato Group to Present at Upcoming Investor Conferences
Business Wire
Stevanato Group Adding New Capacity in Italy Amid Growing Demand for Its Market-Leading Solutions
Motley Fool
Stevanato Group S.p.A. (STVN) Q1 2022 Earnings Call Transcript
Business Wire
Stevanato Group Reports First Quarter 2022 Financial Results
Business Wire
Stevanato Group Publishes Materials for 2022 Annual General Meeting
Business Wire
Stevanato Group and Owen Mumford Sign Exclusive Collaboration Agreement for the Innovative Aidaptus® Auto-Injector
Business Wire
Stevanato Group S.p.A. and Bexson Biomedical, Inc. Expand Collaboration to Treat a Range of Mental Health Conditions With an On-body Device
Business Wire
Stevanato Group to Report First Quarter 2022 Financial Results on May 10, 2022

Profile

Stevanato Group S.p.A. is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. Stevanato Group S.p.A. is based in PIOMBINO DESE, Italy.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.